BRYTLY
- Product NDC
- 0065-8596
- Requested package NDC
- 0065-8596-04
- 11-digit product format
- 000658596
- Labeler code
- 0065
- Product ID
- 0065-8596_11291732-f127-4857-9b74-4409975ac779
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Apraclonidine Hydrochloride
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Alcon Laboratories, Inc.
- Application
- NDA220341
- Marketing category
- NDA
- Marketing start
- 2026-10-16
- Substance
- APRACLONIDINE HYDROCHLORIDE
- Active strength
- 1.25 mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N220341-001 | BRYTLY | APRACLONIDINE HYDROCHLORIDE | EQ 0.125% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2026-10-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N220341-001 | BRYTLY | EQ 0.125% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2026-10-16 | d4dbc9d85df4… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BRYTLY
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| APRACLONIDINE HYDROCHLORIDE | 1.25 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| D2VW67N38H | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a64eaf7f-448e-4def-bddc-f6919d06b357 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BRYTLY | APRACLONIDINE HYDROCHLORIDE | Alcon Laboratories, Inc. | a64eaf7f-448e-4def-bddc-f6919d06b357 | 2026-10-28 | Warnings | 220341 NDA220341 0065-8596-04 0065-8596 00065859604 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0065-8596-04 | 00065859604 | 1 BOTTLE in 1 CARTON (0065-8596-04) / 5 mL in 1 BOTTLE | 1 bottle | 2026-10-16 | No | No | Current |